Description
Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) – Global Forecast to 2030
Product Overview
Healthcare analytical testing services are widely used by pharmaceutical, biopharmaceutical, and medical device manufacturers that support throughout the stages of their drug development. These services provide support in the process of drug development started from discovery through clinical development or clinical trials to commercial use.
Market Overview
The global healthcare analytical testing services market size is projected to reach USD 11.2 billion by 2030 from USD 5.1 billion in 2020, at a CAGR of 12.4%. In the current global scenario-where the focus on biologics and biosimilars has risen-it is expected that the benefits of advanced healthcare analytical testing services will ensure their greater adoption. The increasing demand for specialized testing services, the number of clinical trials, and the acceptance of the QbD approach in pharmaceutical research and manufacturing are other factors driving the growth of this market.
The batch-release testing segment is projected to grow at the highest CAGR during the forecast period
Within the type segment, the market is segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, batch-release testing services, stability testing services, microbial testing services, and environmental monitoring services. The batch-release testing segment is projected to grow at the highest CAGR during the forecast period. Within the batch-release testing services segment, the dissolution testing services market is projected to grow at the highest growth rate during the forecast period.
Pharmaceutical & biopharmaceutical companies hold the largest share in the market
Market Dynamics
The growing outsourcing of analytical testing by pharmaceutical companies, focus on analytical testing of biologics and biosimilars, increasing acceptance of the quality-by-design approach in pharma research and manufacturing are some of the factors behind the growth of the healthcare analytical testing services market in the forecast period of 2020 to 2027. On the other hand, the increasing demand for specialized analytical testing services will create several opportunities that will lead to the growth of the healthcare analytical testing services market in the above mentioned period.
Dearth of skilled professionals will act as a restraint to the growth of the healthcare analytical testing services market in the above mentioned period. But, the necessity to improve the sensitivity of bioanalytical methods will act as a challenge to the healthcare analytical testing services market growth.
North America holds the largest share in the healthcare analytical testing services market, by region
North America held the largest share in the healthcare analytical testing services market in 2019. This dominance of North America in this market is due to the presence of many pharmaceutical and biopharmaceutical companies, high investments and rising focus on the biosimilars & biologics segment, and high allocation to R&D. The Asia Pacific market is expected to register the highest growth during the forecast period, primarily due to the lower production costs and growing favorability of the regulatory environment.
Key market players
The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), LabCorp (US), SGS (Switzerland), Charles River Laboratories (US), WuXi PharmaTech (China), PPD (US), Element Materials Technology (UK), Pace Analytical (US), Intertek (UK), Merck KGAA (Germany), Source BioScience (UK), Almac Group (Ireland), ICON (Ireland), Frontage Labs (US), STERIS PLC (US), PRA Health Sciences (US), Syneos Health (US), Medpace Holdings (US), LGC Limited (UK), and Anacura (Belgium).
By Type
• Bioanalytical Testing Services
o Cell-based Assays
o Virology Testing
o Immunogenicity & Neutralizing Antibody Testing
o Biomarker Testing
o Pharmacokinetic Testing
o Other Bioanalytical Testing Services
• Physical Characterization Services
o Laser Particle Size Analysis
o Thermal Analysis
o Image Analysis
o Surface Area Analysis
o Other Physical Characterization Services
• Method Development & Validation Services
o Extractable & Leachable Method Development & Validation;
o Process Impurity Method Development & Validation;
o Stability-indicating Method Validation
o Cleaning Validation
o Analytical Standard Characterization
o Technical Consulting
o Other Method Development & Validation Services
• Raw Material Testing Services
o Complete Compendial Testing
o Heavy Metal Testing
o Container Testing
o Karl Fischer Analysis
o Wet Chemistry Analysis
o Other Raw Material Testing Services
• Batch-release Testing Services
o Dissolution Testing
o Elemental Impurity Testing
o Disintegration Testing
o Hardness Testing
o Friability Testing
o Other Batch-release Testing Services
• Stability Testing
o Drug Substance Stability Testing
o Formulation Evaluation Stability Testing
o Accelerated Stability Testing
o Photostability Testing
o Comparative Stability Testing
o Other Stability Testing Services
• Microbial Testing Services
o Microbial Limit Testing
o Sterility Testing
o Endotoxin Testing
o Preservative Efficacy Testing
o Water Testing
o Other Microbial Testing Services
• Environmental Monitoring Services
o Air Testing
o Wastewater/ETP Testing
o Other Environmental Monitoring Services
By End User
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Contract Research Organizations
